375 related articles for article (PubMed ID: 17391385)
41. Detection of nosocomial Clostridium difficile infections with toxigenic strains despite negative toxin A and B testing on stool samples.
Stahlmann J; Schönberg M; Herrmann M; von Müller L
Clin Microbiol Infect; 2014 Sep; 20(9):O590-2. PubMed ID: 24450741
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of two enzyme immunoassays for detection of Clostridium difficile toxins A and B in swine.
Anderson MA; Songer JG
Vet Microbiol; 2008 Apr; 128(1-2):204-6. PubMed ID: 18006252
[TBL] [Abstract][Full Text] [Related]
43. [Identification of toxigenic Clostridium difficile strains isolated from alimentary tract of dogs by PCR].
Martirosian G; Meisel-Mikolajczyk F; Stańczak J; Mierzejewski J; Flis D
Med Dosw Mikrobiol; 1994; 46(3):201-6. PubMed ID: 7996938
[TBL] [Abstract][Full Text] [Related]
44. [Comparison of three enzyme immunoassays for detection of Clostridium difficile toxins A and B].
Ould-Hocine ZF; Djibo N; Deforges L; Legrand P; Cattoir V
Pathol Biol (Paris); 2008; 56(7-8):424-8. PubMed ID: 18824307
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of biosite triage Clostridium difficile panel for rapid detection of Clostridium difficile in stool samples.
Landry ML; Topal J; Ferguson D; Giudetti D; Tang Y
J Clin Microbiol; 2001 May; 39(5):1855-8. PubMed ID: 11326003
[TBL] [Abstract][Full Text] [Related]
46. Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes.
Huang H; Wu S; Wang M; Zhang Y; Fang H; Palmgren AC; Weintraub A; Nord CE
Int J Antimicrob Agents; 2009 Apr; 33(4):339-42. PubMed ID: 19097757
[TBL] [Abstract][Full Text] [Related]
47. New variants of the tet(M) gene in Clostridium difficile clinical isolates harbouring Tn916-like elements.
Spigaglia P; Barbanti F; Mastrantonio P
J Antimicrob Chemother; 2006 Jun; 57(6):1205-9. PubMed ID: 16565156
[TBL] [Abstract][Full Text] [Related]
48. Molecular characterization of Clostridium difficile isolates from horses in an intensive care unit and association of disease severity with strain type.
Magdesian KG; Dujowich M; Madigan JE; Hansen LM; Hirsh DC; Jang SS
J Am Vet Med Assoc; 2006 Mar; 228(5):751-5. PubMed ID: 16506942
[TBL] [Abstract][Full Text] [Related]
49. A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genes.
McEllistrem MC; Carman RJ; Gerding DN; Genheimer CW; Zheng L
Clin Infect Dis; 2005 Jan; 40(2):265-72. PubMed ID: 15655746
[TBL] [Abstract][Full Text] [Related]
50. [PCR cloning of 3'-terminal repeat fragments of Clostridium difficile toxin A and toxin B gene].
Yang XQ; Jiang B; Sun Y; Wang JD
Di Yi Jun Yi Da Xue Xue Bao; 2002 Sep; 22(9):791-3. PubMed ID: 12297432
[TBL] [Abstract][Full Text] [Related]
51. Molecular characterization and antimicrobial susceptibilities of extra-intestinal Clostridium difficile isolates.
Zheng L; Citron DM; Genheimer CW; Sigmon SF; Carman RJ; Lyerly DM; Goldstein EJ
Anaerobe; 2007; 13(3-4):114-20. PubMed ID: 17531516
[TBL] [Abstract][Full Text] [Related]
52. Emergence and control of fluoroquinolone-resistant, toxin A-negative, toxin B-positive Clostridium difficile.
Drudy D; Harnedy N; Fanning S; Hannan M; Kyne L
Infect Control Hosp Epidemiol; 2007 Aug; 28(8):932-40. PubMed ID: 17620240
[TBL] [Abstract][Full Text] [Related]
53. Characterisation of Clostridium difficile isolates by slpA and tcdC gene sequencing.
Joost I; Speck K; Herrmann M; von Müller L
Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S13-8. PubMed ID: 19303562
[TBL] [Abstract][Full Text] [Related]
54. First isolation of Clostridium difficile PCR ribotype 027 from a patient with severe persistent diarrhoea in Hungary.
Terhes G; Urbán E; Konkoly-Thege M; Székely E; Brazier JS; Kuijper EJ; Nagy E
Clin Microbiol Infect; 2009 Sep; 15(9):885-6. PubMed ID: 19702592
[TBL] [Abstract][Full Text] [Related]
55. Distinct ribotypes and rates of antimicrobial drug resistance in Clostridium difficile from Shanghai and Stockholm.
Huang H; Fang H; Weintraub A; Nord CE
Clin Microbiol Infect; 2009 Dec; 15(12):1170-3. PubMed ID: 19624517
[TBL] [Abstract][Full Text] [Related]
56. High proportion of false-positive Clostridium difficile enzyme immunoassays for toxin A and B in pediatric patients.
Toltzis P; Nerandzic MM; Saade E; O'Riordan MA; Smathers S; Zaoutis T; Kim J; Donskey CJ
Infect Control Hosp Epidemiol; 2012 Feb; 33(2):175-9. PubMed ID: 22227987
[TBL] [Abstract][Full Text] [Related]
57. Serogroup F strains of Clostridium difficile produce toxin B but not toxin A.
Depitre C; Delmee M; Avesani V; L'Haridon R; Roels A; Popoff M; Corthier G
J Med Microbiol; 1993 Jun; 38(6):434-41. PubMed ID: 8510136
[TBL] [Abstract][Full Text] [Related]
58. [Detection of toxin producing strains of Clostridium difficile using rapid diagnostic methods].
Pituch H; Obuch-Woszczatyński P; Rouyan GS; Martirosian G; Meisel-Mikołajczyk F
Med Dosw Mikrobiol; 1998; 50(1-2):55-61. PubMed ID: 9857614
[TBL] [Abstract][Full Text] [Related]
59. Clostridium difficile infections in HIV-positive patients.
Wongwanich S; Ramsiri S; Kusum M; Warachit P
Southeast Asian J Trop Med Public Health; 2000 Sep; 31(3):537-9. PubMed ID: 11289016
[TBL] [Abstract][Full Text] [Related]
60. In vitro activity of cadazolid against Clostridium difficile strains isolated from primary and recurrent infections in Stockholm, Sweden.
Rashid MU; Lozano HM; Weintraub A; Nord CE
Anaerobe; 2013 Apr; 20():32-5. PubMed ID: 23454525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
